FOIA to FDA Seeking Records Related to Orphan-Drug Designation Requests for COVID-19 Treatments

FOIA to the Food and Drug Administration seeking records sufficient to identify, with respect to requests for orphan-drug designation for treatments for COVID-19, the requester’s name, the date of the request, and the name of the treatment. HHS-FDA-20-0719